本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mereo Biopharma Group Plc

2.59
+0.07002.78%
成交量:80.62萬
成交額:205.37萬
市值:4.12億
市盈率:-8.86
高:2.60
開:2.49
低:2.46
收:2.52
資料載入中...
2025/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/26

重要事件披露

Form 8-K - Current report
2025/01/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/03

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities